NBIX peer analysis

Neurocrine Biosciences (NBIX) against its competitors: price, today's move, 1-year return and market value side by side.

NBIX and its peers

CompanyPriceToday1-year returnMarket cap
ACAD Acadia Pharmaceuticals$17.12-2.67%-25.89%$2.96B
AXSM Axsome Therapeutics$129.36-4.66%-11.86%$6.80B
BHVN Biohaven$12.51-8.35%32.24%$1.89B
GHRS GH Research$17.53-5.55%21.91%$1.20B
JAZZ Jazz Pharmaceuticals$230.62-2.47%30.97%$14.80B
NMRA Neumora Therapeutics$0.35-5.40%-86.34%$65.48M
RAPP Rapport Therapeutics$23.16-1.82%-13.84%$1.11B
SUPN Supernus Pharmaceuticals$28.00-1.23%-37.64%$3.30B
VNDA Vanda Pharmaceuticals$3.46-5.72%-32.68%$209.23M
NBIX Neurocrine Biosciences$150.57-3.84%9.06%$15.24B